title: [Osteodeficiency in chronic pancreatitis: ways of correction].
abstract: The expediency of Vitrum Calcium 600 + D400 and Risendros using in the complex treatment of the patients with a chronic pancreatitis and osteodeficiency syndrome has been proved. As a result the status of the bone mineralization is improved, the mineral density of the bone tissue is increased.
authors.forename: L S
authors.initials: LS
authors.lastname: Babinets'
authors.forename: I V
authors.initials: IV
authors.lastname: Semenova
authors.forename: I O
authors.initials: IO
authors.lastname: Borovyk
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002113:Calcification, Physiologic / Q000187:drug effects; D002119:Calcium Carbonate / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000627:therapeutic use*; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D050500:Pancreatitis, Chronic / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000068296:Risedronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D002762:Cholecalciferol; D002119:Calcium Carbonate; D000068296:Risedronic Acid; D012968:Etidronic Acid